StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$21.04+0.96 (+4.78%)

Close on Nov 18, 2026Market cap $411.32MP/E –Yield 0.00%

Tectonic Therapeutic gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Tectonic Therapeutic

Tectonic Therapeutic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tectonic Therapeutic figures

See a number that looks wrong?